About the Product

Description


Lacomasid 150 Tablet containing Lacosamide is used for the management of seizure disorders and epilepsy. It helps control abnormal electrical activity in the brain and supports better neurological stability.

Lacosamide works by selectively enhancing the slow inactivation of voltage-gated sodium channels, helping stabilize overactive nerve cells and reduce the occurrence of seizures.

The tablet is widely prescribed in neurology practice for the management of partial-onset seizures and related epileptic conditions, leading to consistent prescription demand.

With increasing awareness of neurological health and growing demand for advanced antiepileptic therapies, this product offers strong business potential for retailers and distributors. Its established therapeutic efficacy, broad clinical relevance, and steady market demand make it a reliable product for growth in the neurocare segment.

Some patients may experience dizziness, headache, nausea, vomiting, double vision, blurred vision, fatigue, sleepiness, or problems with coordination. Rarely, cardiac conduction abnormalities, severe allergic reactions, mood changes, or suicidal thoughts may occur and require immediate medical attention.

Lacomasid 150 Tablet is indicated for the treatment of partial-onset seizures in patients with epilepsy. It may be used alone or in combination with other antiepileptic medications as prescribed by a healthcare professional. It helps reduce seizure frequency and supports long-term epilepsy management.

This medicine should be used strictly under medical supervision. Do not stop treatment abruptly, as sudden discontinuation may increase the risk of seizures. Use cautiously in patients with heart rhythm disorders, liver impairment, kidney disease, or psychiatric conditions. Patients should avoid driving or operating machinery if dizziness or visual disturbances occur.

Store in a cool, dry place below 25°C, protected from moisture and direct sunlight. Keep the tablets in their original packaging and out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

What are the business opportunities for Lacosamide 150mg Tablet in the PCD pharma franchise market?

Lacosamide 150mg Tablet has strong demand in the neurology, epilepsy management, and CNS (Central Nervous System) segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on neuro-care and specialty healthcare portfolios.

Why should medical distributors include Lacosamide 150mg Tablet in their product range?

Medical distributors and agencies can benefit from consistent demand for seizure disorder management under medical supervision. Lacosamide 150mg is an antiepileptic medication used in the management of seizure disorders Commonly prescribed for partial-onset seizures and other epilepsy-related conditions as determined by healthcare professionals Helps stabilize electrical activity in the brain and supports long-term seizure control Widely prescribed by neurologists and epilepsy specialists Higher-strength formulation provides flexibility in individualized treatment plans This strengthens a comprehensive neurology and CNS care portfolio.

Does Cafoli LifeCare Pvt Ltd offer PCD pharma franchise opportunities for this tablet?

Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Lacosamide 150mg Tablet with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.

What benefits do wholesalers get by partnering for this product?

Wholesalers and medical agencies benefit from steady prescription demand in neurology practice, long-term therapy usage, repeat orders, reliable supply chain support, and attractive margins in the CNS segment.

How can I become a distributor or franchise partner for this product?

Interested distributors, stockists, and wholesalers can contact Cafoli LifeCare Pvt Ltd to explore PCD pharma franchise opportunities, discuss pricing and business terms, obtain monopoly territory rights, and benefit from comprehensive marketing support, quality pharmaceutical products, and a dependable supply chain to grow their business successfully.